Autoantibodies to survivin in the sera of patients with infiltrating ductal carcinoma of the breast

Medical Journal of Malaysia

Volumn 61, Issue 3, 2006, Pages 302-306

  Al Joudi, Fawwaz S ^a   Iskandar, Z A ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Autoantibodies; Breast cancer; Survivin

Indexed keywords

AUTOANTIBODY; SURVIVIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE;

ADULT; AGED; AUTOANTIBODIES; BREAST NEOPLASMS; CARCINOMA, DUCTAL; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 33751569085     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ronai Z and Sulitzeanu D. Autoantibodies in human breast cancer sera against antigens associated with breast cancer cells, detected by immunoblotting. J. Natl Cancer Inst. 1986; 77(6): 1203-209.
2. Humphrey LJ, Volenec PJ, Estes NC and Volenec FJ. Autoantigens in breast cancer tissue. J Surg Oncol 1979; 11(2): 141-52.
3. Howard DR and Taylor CR. A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human sera. Cancer 1979; 43(6): 2279-87.
4. Holder WD and Wells SA. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma. Cancer Res 1983; 43(1): 239-44.
5. Howard DR and Taylor CR. An antitumor in normal human serum: reaction of anti-T with breast carcinoma cells. Oncology 1980; 37(3): 142-48.
6. Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001; 108: 1411-15.
7. Covini G, Chan EK, Nishioka M, Morshed SA. Reed SI and Tan EM. Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology 1977; 25: 75-80.
8. Kao H, Marto JA, Hoffman TK, Shabanowitz J, Finkelstein SD, Whiteside TL, Hunt DF, and Finn OJ. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J Exp Med 2001; 194: 1313-23.
9. Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A. Schmitz M, Mehlhorn J, Conrad K and Rieber EP. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res 2000; 60: 1815-17.
10. Yagihashi A, Asanuma K, Nakamura M, Araya J, Mano Y, Torigoe T, Kobayashi D and Watanahe N. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem 2001; 47(9): 1729-31.
11. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N and Watanabe N. Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung Cancer 2005; 48(2): 217-21.
12. Zhang JY. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detection and Prevention 2004; 28: 114-18.
13. Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirta K, Watanabe N. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta 2005; 362 (1-2): 125-30.
14. Campbell AM, McCormack A. Ross CA and Leake RE. Immunological analysis of the autologous humoral response in breast cancer. Br J Cancer 1986: 53 (1): 7-11.